Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/95 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839574497260208128 |
---|---|
author | E. V. Kataeva A. K. Golenkov E. V. Trifonova G. A. Dudina T. A. Mitina L. L. Vysotskaya T. D. Lutskaya I. V. Buravtsova R. V. Gorenkov Yu. Yu. Chuksina V. V. Yazdovskiy |
author_facet | E. V. Kataeva A. K. Golenkov E. V. Trifonova G. A. Dudina T. A. Mitina L. L. Vysotskaya T. D. Lutskaya I. V. Buravtsova R. V. Gorenkov Yu. Yu. Chuksina V. V. Yazdovskiy |
author_sort | E. V. Kataeva |
collection | DOAJ |
description | In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine. |
format | Article |
id | doaj-art-d57836c8e8bb4e5080ac6ce12f081036 |
institution | Matheson Library |
issn | 1818-8346 2413-4023 |
language | Russian |
publishDate | 2014-07-01 |
publisher | ABV-press |
record_format | Article |
series | Онкогематология |
spelling | doaj-art-d57836c8e8bb4e5080ac6ce12f0810362025-08-04T13:57:48ZrusABV-pressОнкогематология1818-83462413-40232014-07-01624710.17650/1818-8346-2011-6-2-4-7110Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabineE. V. Kataeva0A. K. Golenkov1E. V. Trifonova2G. A. Dudina3T. A. Mitina4L. L. Vysotskaya5T. D. Lutskaya6I. V. Buravtsova7R. V. Gorenkov8Yu. Yu. Chuksina9V. V. Yazdovskiy10M.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteM.F. Vladimirsky Moscow Regional Research Clinical InstituteIn present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.https://oncohematology.abvpress.ru/ongm/article/view/95chronic lymphocytic leukemiaresistant patientsalemtuzumabfludarabine |
spellingShingle | E. V. Kataeva A. K. Golenkov E. V. Trifonova G. A. Dudina T. A. Mitina L. L. Vysotskaya T. D. Lutskaya I. V. Buravtsova R. V. Gorenkov Yu. Yu. Chuksina V. V. Yazdovskiy Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine Онкогематология chronic lymphocytic leukemia resistant patients alemtuzumab fludarabine |
title | Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
title_full | Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
title_fullStr | Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
title_full_unstemmed | Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
title_short | Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine |
title_sort | treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab alone or in combination with fludarabine |
topic | chronic lymphocytic leukemia resistant patients alemtuzumab fludarabine |
url | https://oncohematology.abvpress.ru/ongm/article/view/95 |
work_keys_str_mv | AT evkataeva treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT akgolenkov treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT evtrifonova treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT gadudina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT tamitina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT llvysotskaya treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT tdlutskaya treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT ivburavtsova treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT rvgorenkov treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT yuyuchuksina treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine AT vvyazdovskiy treatmentofpatientswithrefractorychroniclymphocyticleukemiawithalemtuzumabaloneorincombinationwithfludarabine |